---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016120"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-19T00:11:55.556827+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma stockholders elect 8 directors and ratify Crowe LLP as 2025 auditor

## Summary
- All 8 director nominees elected with 'for' votes ranging from 13.4M to 14.6M; broker non-votes 5.5M across all director proposals.
- Ratification of Crowe LLP as independent auditor approved with 19.9M for, 47.6K against, 98.4K abstentions (no broker non-votes).
- 72.1% of outstanding shares (20.1M) were present or represented at the June 20, 2025 annual meeting.

## SEC filing metadata
- accession: 0001641172-25-016120
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000164117225016120/0001641172-25-016120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000164117225016120/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016120
- JSON: https://secwatch.observer/filing/0001641172-25-016120.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.